Latest revision as of 09:55, 20 March 2024
Information about message (contribute ) This message has no documentation.
If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Biosimilar ) {{Short description|Variant of a biopharmaceutical}} A '''biosimilar''' (also known as '''follow-on biologic''' or '''subsequent entry biologic''') is a [[biopharmaceutical|biologic medical product]] that is almost an identical copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products and can be manufactured when the original product's [[chemical patent|patent]] expires. Reference to the innovator product is an integral component of the approval.
バイオシミラー (biosimilar )(follow-on biologic またはaftersequent entry biologic とも呼ばれる)とは、生物学的製剤 であり、他社が製造する先発品とほぼ同一のコピーである。バイオシミラーとは、「イノベーター」である先発品の正式な承認版であり、先発品の特許 が切れた時点で製造が可能となる。イノベーター製品への言及は承認に不可欠な要素である。